In order to verify the above experimental results, we measured the tumor-infiltrating levels of B cells, CD8+ T cells, and M2 macrophages at high or low expression of ASPM in KIRC and LIHC using quantitative immunofluorescence. This evidence concerns the gene CD8A and neoplasm.